Breaking News

Evonik Launches MaxiPure Polysorbate 80

Excipient addresses key challenges such as protein stability, viral inactivation, and the consistent solubilization of hydrophobic APIs.

Author Image

By: Charlie Sternberg

Associate Editor

Evonik has launched MaxiPure Polysorbate 80, a highly pure surfactant designed for injectable and biopharmaceutical applications. This ultra-high purity excipient addresses key challenges such as protein stability, viral inactivation, and the consistent solubilization of hydrophobic active pharmaceutical ingredients (APIs). “MaxiPure Polysorbate 80 is a strategic addition to our excipients portfolio. Its exceptional purity, coupled with our strong regulatory support, reflect our deep commitme...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters